Valuation: Nephros, Inc.

Market Cap 36.8M 31.99M 29.78M 27.34M 51.63M 3.51B 52.43M 351M 138M 1.75B 138M 135M 5.86B P/E 2026 *
84.8x
P/E 2027 * 23.4x
Enterprise Value 36.8M 31.99M 29.78M 27.34M 51.63M 3.51B 52.43M 351M 138M 1.75B 138M 135M 5.86B EV / Sales 2026 *
1.76x
EV / Sales 2027 * 1.55x
Free-Float
87.13%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: Nephros, Inc.

Manager TitleAgeSince
Chief Executive Officer 51 05/05/2023
Director of Finance/CFO 60 01/11/2023
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 69 19/09/2007
Director/Board Member 54 10/08/2018
Director/Board Member 58 08/09/2022
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-1.69% - - 36.8M
-0.27%-16.33% - - 14.58B
+1.71%+1.56%+32.98%+49.35% 10.92B
-0.24%-2.37%+60.93%+283.38% 4.24B
+0.53%-12.88%+46.00%+459.34% 3.85B
+3.58%-7.92%+42.79%+79.26% 1.24B
+11.12%-13.85% - - 1.08B
+1.05%+3.21%-20.76%-17.73% 910M
+4.73%-0.97%+120.24%+122.75% 876M
+2.10%-1.66%+185.61%+176.98% 750M
Average +2.43%-5.96%+66.83%+164.76% 4.27B
Weighted average by Cap. +1.01%-8.02%+47.15%+168.08%

Financials

2026 *2027 *
Net sales 20.92M 18.18M 16.93M 15.54M 29.35M 2B 29.8M 200M 78.3M 994M 78.56M 76.84M 3.33B 23.8M 20.69M 19.26M 17.68M 33.39M 2.27B 33.91M 227M 89.1M 1.13B 89.39M 87.43M 3.79B
Net income 461K 401K 373K 343K 647K 44.04M 657K 4.4M 1.73M 21.92M 1.73M 1.69M 73.52M 1.63M 1.42M 1.32M 1.21M 2.29M 156M 2.32M 15.56M 6.11M 77.51M 6.13M 5.99M 260M
Net Debt - -
Logo Nephros, Inc.
Nephros, Inc. is a water technology company providing filtration solutions to the medical and commercial markets. The Company provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-